Clariane stock among SBF 120's strongest gainers, driven by Q3 results
The medicalised retirement homes and home care services group is enjoying a very strong trading session in a well-oriented Paris market. The movement follows the publication of its third quarter activity and erases part of the decline in recent weeks.
Revenue up 4.9% organically in Q3, driven by facility occupancy rates
Clariane stock gains 4.98% to €3.41 in trading, placing it among the strongest gainers of the SBF 120, which is up 1.1%. Third quarter revenue, published on October 28, reached €1,352 million, up 4.9% organically and 2.4% on a reported basis.
The pace is comparable to that of the previous two quarters. The average occupancy rate for medicalised retirement homes stands at 92.2% over nine months, compared with 90.8% a year earlier, and reaches 91.1% in France for the quarter alone.
In its statement, the group states: "Strong with these results, we confidently confirm all of our operational and financial targets." It notably aims for an average annual organic revenue growth of around 5%.
CIC Market Solutions maintains its buy rating with a price target of €5.20, representing upside potential of over 50% compared to current levels.
A rebound that reclaims the 20-day moving average but remains below the 50-day and 200-day moving averages following a one-year low
The stock touched a one-year low of €3.15 on October 22, after declining nearly 16% in one month. It has advanced 4.4% over seven days but remains down 9.4% over one month. It stands 3.71% above its 20-day moving average (€3.29), while the 50-day moving average (€3.67) remains 7.03% above the price and the 200-day moving average (€3.89) is 12.29% higher.
The RSI at 49 is neutral. Emeis, another player in the sector, gains 3.08% on Thursday, after declining 4.15% over one month. The next chart level is resistance at €3.99, while support at €3.11 was tested the previous day.
